Singapore markets close in 2 hours 5 minutes

Lantheus Holdings, Inc. (LNTH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
81.31+2.79 (+3.55%)
At close: 04:00PM EDT
81.49 +0.18 (+0.22%)
After hours: 05:01PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close78.52
Open79.70
Bid81.28 x 300
Ask81.46 x 600
Day's range78.88 - 81.34
52-week range50.20 - 91.81
Volume747,763
Avg. volume821,751
Market cap5.636B
Beta (5Y monthly)0.56
PE ratio (TTM)12.39
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers

    Deal Further Strengthens Lantheus’ Prostate Cancer Portfolio and Expands Pipeline to Include Breast CancerBEDFORD, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced its acquisition of the global rights of Life Molecular Imaging’s (“Life Molecular”) RM2, targeting the gastrin-releasing pep

  • GlobeNewswire

    Radiopharm Receives Strategic Investment for up to A$18 million

    Lantheus has agreed to make an initial strategic equity investment of A$7.5 million in RadiopharmOffer price for the shares of A$0.05 represents a 47% premium to the last closing price of $0.034 on 19 June 2024Option for Lantheus to invest a further A$7.5m within 6 months on the same termsLantheus will also secure rights to two early preclinical assets in exchange for an A$3m upfront payment pursuant to a transfer and development agreement SYDNEY, June 20, 2024 (GLOBE NEWSWIRE) -- Radiopharm The

  • GlobeNewswire

    Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform

    The integrated aPROMISE solution to be demonstrated on Siemens Healthineers’ syngo.via platform at the SNMMI annual meetingBEDFORD, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that aPROMISE, its AI-enabled FDA-cleared medical device software, is now available on the syngo.via platfo